Dachaigh › Luchd-obrach › MedPharm Manufacturing Services LLC
MedPharm Manufacturing Services LLC: Tuarastalan H-1B agus taic bhìosa
Chuir MedPharm Manufacturing Services LLC 8 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 7. Tuarastal meadhanach a chaidh a thabhann: $103,000.
A bheil MedPharm Manufacturing Services LLC a’ toirt taic do bhìosaichean H-1B?
Chuir MedPharm Manufacturing Services LLC 8 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 1 Cèit 2026. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Analytical Scientist III | 2 | $103,000 |
| Scientist III, Analytical R&D | 1 | $100,000 |
| Associate Director | 1 | $142,744 |
| Senior Manager, Quality Control & Stability | 1 | $109,128 |
| QC Chemist III | 1 | $96,395 |
| Manager, Pharmaceutical Sciences | 1 | $124,663 |
| Scientist II, Analytical R&D | 1 | $80,247 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2025 | 5 | $106,064 |
| FY2026 | 3 | $96,395 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Chemists5
- Natural Sciences Managers1
- Molecular and Cellular Biologists1
- Medical Scientists, Except Epidemiologists1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Scientist II, Analytical R&D | $80,247 Ìre I | Durham, NC | 1 Cèit 2026 | 8 Sult 2026 | Dearbhaichte |
| QC Chemist III | $96,395 Ìre III | Durham, NC | 19 Samh 2025 | 6 Gibl 2026 | Dearbhaichte |
| Manager, Pharmaceutical Sciences | $124,663 Ìre IV | Durham, NC | 19 Samh 2025 | 13 Gearr 2026 | Dearbhaichte |
| Scientist III, Analytical R&D | $100,000 Ìre III | Durham, NC | 20 Ògmh 2025 | 7 Samh 2025 | Dearbhaichte |
| Associate Director | $142,744 Ìre II | Durham, NC | 9 Ògmh 2025 | 7 Samh 2025 | Dearbhaichte |
| Senior Manager, Quality Control & Stability | $109,128 Ìre IV | Durham, NC | 9 Ògmh 2025 | 25 Iuch 2025 | Dearbhaichte |
| Analytical Scientist III | $103,000 Ìre III | Durham, NC | 9 Cèit 2025 | 19 Cèit 2025 | Dearbhaichte |
| Analytical Scientist III | $103,000 Ìre III | Durham, NC | 9 Cèit 2025 | 19 Cèit 2025 | Air a tharraing air ais |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).